United States. Food and Drug Administration. (1998). Information sheet: Guidance for institutional review boards and clinical investigators ("off-label" and investigational use of marketed drugs, biologics, and medical devices). [U.S. Dept. of Health and Human Services, Food and Drug Administration].
Chicago Style (17th ed.) CitationUnited States. Food and Drug Administration. Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators ("off-label" and Investigational Use of Marketed Drugs, Biologics, and Medical Devices). [Rockville, Md.]: [U.S. Dept. of Health and Human Services, Food and Drug Administration], 1998.
MLA (9th ed.) CitationUnited States. Food and Drug Administration. Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators ("off-label" and Investigational Use of Marketed Drugs, Biologics, and Medical Devices). [U.S. Dept. of Health and Human Services, Food and Drug Administration], 1998.